Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: A link to spasticity

Brain

Volumn 136, Issue 2, 2013, Pages 483-493

  Dentel, Christel ^a,b,c   Palamiuc, Lavinia ^a,b   Henriques, Alexandre ^a,b   Lannes, Béatrice ^b,c   Spreux Varoquaux, Odile ^d,e   Gutknecht, Lise ^f,g   René, Frédérique ^a,b   Echaniz Laguna, Andoni ^a,b,c   Gonzalez De Aguilar, Jose Luis ^a,b   Lesch, Klaus Peter ^f,h   Meininger, Vincent ^i,j   Loeffler, Jean Philippe ^a,b   Dupuis, Luc ^a,b,j,k  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e CENTRE HOSPITALIER DE VERSAILLES   (France)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g UNIV MONTPELLIER   (France)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ SORBONNE UNIVERSITÉ   (France)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^k UNIVERSITY OF ULM   (Germany)

more..

Author keywords

ALS; animal models; motor neuron; serotonin; spasticity

Indexed keywords

SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; TRYPTOPHAN HYDROXYLASE 2;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DISEASE ASSOCIATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MECHANICAL STIMULATION; MOTONEURON; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; SPASTICITY; SPINAL CORD;

EID: 84874307126     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws274     Document Type: Article

References (45)

1. Alvarez JC, Bothua D, Collignon I, Advenier C, Spreux-Varoquaux O. Simultaneous measurement of dopamine, serotonin, their metabolites and tryptophan in mouse brain homogenates by high-performance liquid chromatography with dual coulometric detection. Biomed Chromatogr 1999; 13: 293-8.
2. Ashworth NL, Satkunam LE, Deforge D. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2006; 1: CD004156.
3. Ashworth NL, Satkunam LE, Deforge D. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2012; 2: CD004156.
4. Bennett DJ, Sanelli L, Cooke CL, Harvey PJ, Gorassini MA. Spastic long-lasting reflexes in the awake rat after sacral spinal cord injury. J Neurophysiol 2004; 91: 2247-58.
5. Bertel O, Malessa S, Sluga E, Hornykiewicz O. Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord. Brain Res 1991; 566: 54-60.
6. Braunstein KE, Eschbach J, Rona-Voros K, Soylu R, Mikrouli E, Larmet Y, et al. A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. Hum Mol Genet 2010; 19: 4385-98.
7. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-9.
8. Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001; 191: 133-7.
9. Dupuis L, de Tapia M, Rene F, Lutz-Bucher B, Gordon JW, Mercken L, et al. Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons. Neurobiol Dis 2000; 7: 274-85.
10. Dupuis L, Spreux-Varoquaux O, Bensimon G, Jullien P, Lacomblez L, Salachas F, et al. Platelet serotonin level predicts survival in amyotrophic lateral sclerosis. PLoS One 2010; 5: e13346.
11. Floeter MK, Zhai P, Saigal R, Kim Y, Statland J. Motor neuron firing dysfunction in spastic patients with primary lateral sclerosis. J Neurophysiol 2005; 94: 919-27.
12. Forrest V, Ince P, Leitch M, Marshall EF, Shaw PJ. Serotonergic neurotransmission in the spinal cord and motor cortex of patients with motor neuron disease and controls: quantitative autoradiography for 5-HT1a and 5-HT2 receptors. J Neurol Sci 1996; 139 (Suppl): 83-90.
13. Franklin K, Paxinos G. The mouse brain in stereotaxic coordinates. San Diego: Academic Press; 1997.
14. Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology 2009; 72: 1948-52.
15. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994; 264: 1772-5.
16. Gutknecht L, Kriegebaum C, Waider J, Schmitt A, Lesch KP. Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol 2009; 19: 266-82.
17. Halter B, Gonzalez de Aguilar JL, Rene F, Petri S, Fricker B, Echaniz-Laguna A, et al. Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 2010; 48: 915-23.
18. Heckman CJ, Mottram C, Quinlan K, Theiss R, Schuster J. Motoneuron excitability: the importance of neuromodulatory inputs. Clin Neurophysiol 2009; 120: 2040-54.
19. Ivanhoe CB, Reistetter TA. Spasticity: the misunderstood part of the upper motor neuron syndrome. Am J Phys Med Rehabil 2004; 83 (10 Suppl): S3-9.
20. Kennett GA, Wood MD, Bright F, Cilia J, Piper DC, Gager T, et al. In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol 1996; 117: 427-34.
21. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet 2011; 377: 942-55.
22. Kuipers-Upmeijer J, de Jager AE, Hew JM, Snoek JW, van Weerden TW. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry 2001; 71: 615-20.
23. Lanfranco MF, Anastasio NC, Seitz PK, Cunningham KA. Quantification of RNA editing of the serotonin 2C receptor (5-HT(C)R) ex vivo. Methods Enzymol 2010; 485: 311-28.
24. Lanfranco MF, Seitz PK, Morabito MV, Emeson RB, Sanders-Bush E, Cunningham KA. An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT(2C)R) in brain. J Neurosci Methods 2009; 179: 247-57.
25. Le Forestier N, Maisonobe T, Spelle L, Lesort A, Salachas F, Lacomblez L, et al. Primary lateral sclerosis: further clarification. J Neurol Sci 2001a; 185: 95-100.
26. Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Crevier-Buchman L, Salachas F, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain 2001b; 124 (Pt 10): 1989-99.
27. Li Y, Li X, Harvey PJ, Bennett DJ. Effects of baclofen on spinal reflexes and persistent inward currents in motoneurons of chronic spinal rats with spasticity. J Neurophysiol 2004; 92: 2694-703.
28. Murray KC, Stephens MJ, Ballou EW, Heckman CJ, Bennett DJ. Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity. J Neurophysiol 2011; 105: 731-48.
29. Murray KC, Nakae A, Stephens MJ, Rank M, D'Amico J, Harvey PJ, et al. Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nat Med 2010; 16: 694-700.
30. Navarrett S, Collier L, Cardozo C, Dracheva S. Alterations of serotonin 2C and 2A receptors in response to T10 spinal cord transection in rats. Neurosci Lett 2012; 506: 74-8.
31. Nebigil CG, Jaffre F, Messaddeq N, Hickel P, Monassier L, Launay JM, et al. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation 2003; 107: 3223-9.
32. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-3.
33. Ozdinler PH, Benn S, Yamamoto TH, Guzel M, Brown RH Jr, Macklis JD. Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G(9)(3)A transgenic ALS mice. J Neurosci 2011; 31: 4166-77.
34. Perrin FE, Gerber YN, Teigell M, Lonjon N, Boniface G, Bauchet L, et al. Anatomical study of serotonergic innervation and 5-HT(1A) receptor in the human spinal cord. Cell Death Dis 2011; 2: e218.
35. Rank MM, Murray KC, Stephens MJ, D'Amico J, Gorassini MA, Bennett DJ. Adrenergic receptors modulate motoneuron excitability, sensory synaptic transmission and muscle spasms after chronic spinal cord injury. J Neurophysiol 2011; 105: 410-22.
36. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995; 92: 689-93.
37. Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 2002; 366: 381-416.
38. Shannon NJ, Gunnet JW, Moore KE. A comparison of biochemical indices of 5-hydroxytryptaminergic neuronal activity following electrical stimulation of the dorsal raphe nucleus. J Neurochem 1986; 47: 958-65.
39. Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle Nerve 2007; 35: 291-302.
40. Sofic E, Riederer P, Gsell W, Gavranovic M, Schmidtke A, Jellinger K. Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis. J Neural Transm Park Dis Dement Sect 1991; 3: 133-42.
41. Swash M. Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry 2012; 83: 659-62.
42. Turner MR, Rabiner EA, Al-Chalabi A, Shaw CE, Brooks DJ, Leigh PN, et al. Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS. Neurology 2007; 68: 1233-5.
43. Turner MR, Rabiner EA, Hammers A, Al-Chalabi A, Grasby PM, Shaw CE, et al. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain 2005; 128 (Pt 4): 896-905.
44. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002; 3.
45. Yoshimoto K, Irizawa Y, Komura S. Rapid postmortem changes of rat striatum dopamine, serotonin, and their metabolites as monitored by brain microdialysis. Forensic Sci Int 1993; 60: 183-8.